GRAPPA 2016 Project Report

REFERENCES

1. 1.↵
   1. Moverley AR,
   2. Vinall-Collier KA,
   3. Helliwell PS

   . It’s not just the joints, it’s the whole thing: qualitative analysis of patients’ experience of flare in psoriatic arthritis. Rheumatology 2015;54:1448–53.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Caperon A,
   2. Helliwell PS

   . Remission in psoriatic arthritis. J Rheumatol Suppl. 2012 Jul;89:19–21.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Moverley A,
   2. Coates L,
   3. Marzo-Ortega H,
   4. Waxman R,
   5. Torgerson D,
   6. Cocks K,
   7. et al.

   A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F)). Clin Rheumatol 2015;34:1407–12.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Araujo EG,
   2. Finzel S,
   3. Englbrecht M,
   4. Schreiber DA,
   5. Faustini F,
   6. Hueber A,
   7. et al.

   High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission. Ann Rheum Dis 2015;74:655–60.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Moverley AR,
   2. Waxman R,
   3. de Wit M,
   4. Parkinson A,
   5. Campbell W,
   6. Brooke M,
   7. et al.

   Development of a flare instrument for use in psoriatic disease: a report from the 2015 GRAPPA Annual Meeting. J Rheumatol 2016;43:974–8.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Mease PJ,
   2. Helliwell PS,
   3. Boehncke WH,
   4. Coates LC,
   5. FitzGerald O,
   6. Gladman DD,
   7. et al.

   GRAPPA 2015 research and education project reports. J Rheumatol 2016;43:979–85.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Callis Duffin K,
   2. Mease PJ

   . Psoriasis and psoriatic arthritis educational initiatives: an update from the 2014 GRAPPA Annual Meeting. J Rheumatol 2015;42:1056–8.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Langley RG,
   2. Feldman SR,
   3. Nyirady J,
   4. van de Kerkhof P,
   5. Papavassilis C

   . The 5-point Investigator’s Global Assessment (IGA) scale: a modified tool for evaluating plaque psoriasis severity in clinical trials. J Dermatolog Treat 2015;26:23–31.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Fredriksson T,
   2. Pettersson U

   . Severe psoriasis—oral therapy with a new retinoid. Dermatologica 1978;157:238–44.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Finlay AY

    . Current severe psoriasis and the rule of tens. Br J Dermatol 2005;152:861–7.

    OpenUrlCrossRefPubMed